This is a profile image of Anna Mattsson

Anna Mattsson


Globally recognized M&A strategy, merger management, and carve-out expert who helps companies achieve more impactful deal outcomes

Anna leads the Strategy & Corporate Finance Practice for Switzerland and coleads M&A strategy and portfolio for the Life Sciences Practice around the world. She is a globally recognized merger management and carve-out advisor specializing in advising boards and management teams in designing, planning, and executing complex, cross-border integrations, separations, and alliances. She also helps her clients develop M&A blueprint and build M&A capabilities.

Anna has close to twenty years of M&A experience, advising clients in buying and selling across the entire M&A value chain. She has supported more than 110 M&A deals, ranging from $200 million to $50 billion. While her industry focus is on life sciences, she has worked across multiple industries, ranging from consumer and industrials to technology.

Anna also has extensive consulting, corporate, and private-equity experience. She regularly lectures on M&A topics at business schools across Europe and has authored numerous studies.

In addition to her work with M&A, she is also passionate about diversity and has served in multiple roles and boards to further diversity and inclusion.

Published work

The equity story you need for the long-term investors you want,” McKinsey Quarterly, February 2024

The power of goodbye: How separations can unleash value,” McKinsey Quarterly, February 2023

Five ways biopharma companies can navigate the deal landscape,” McKinsey & Company, February 2023

Kids or career? Switzerland’s unnecessary dilemma,” Advance Whitepaper, February 2022


Partner, managing partner

Gyrus Capital
Operating-advisory partner

Vice president of the board


University of Gothenburg
MS and BA, business administration and economics